Stay updated on Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial

Sign up to get notified when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error screen, with the footer revision identifier changing from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:55:58.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A site-wide NIH banner was added announcing a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision label changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:58:45.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 while the study page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:13:11.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The Study Record page now displays a 403 Forbidden error, indicating access to the study details is blocked. The page shows a minimal error screen instead of the study content.
    Difference
    18%
    Check dated 2026-09-23T00:07:16.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0, indicating a behind-the-scenes update to the page template or metadata. This change does not alter study data or trial details.
    Difference
    0.0%
    Check dated 2026-09-16T00:28:45.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a newer version of the page. This represents minor maintenance rather than a substantive change to the study information.
    Difference
    0.0%
    Check dated 2026-09-01T20:28:19.000Z thumbnail image

Stay in the know with updates to Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.